blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4316537

EP4316537 - REGENERATION OF DAMAGED TISSUE [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  05.01.2024
Database last updated on 06.07.2024
Most recent event   Tooltip08.03.2024Publication of search reportpublished on 10.04.2024  [2024/15]
08.03.2024Change - classificationpublished on 10.04.2024  [2024/15]
08.03.2024Change - classificationpublished on 10.04.2024  [2024/15]
Applicant(s)For all designated states
Allergan Pharmaceuticals International Limited
Clonshaugh Business & Technology Park
Dublin 17, D17 E400 / IE
[2024/06]
Inventor(s)01 / WEISS, Anthony Steven
New South Wales, 2006 / AU
 [2024/06]
Representative(s)Nederlandsch Octrooibureau
P.O. Box 29720
2502 LS The Hague / NL
[2024/06]
Application number, filing date23206907.013.08.2014
[2024/06]
Priority number, dateAU2013090309213.08.2013         Original published format: AU 2013903092
[2024/06]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP4316537
Date:07.02.2024
Language:EN
[2024/06]
Type: A3 Search report 
No.:EP4316537
Date:10.04.2024
Language:EN
[2024/15]
Search report(s)(Supplementary) European search report - dispatched on:EP11.03.2024
ClassificationIPC:A61K38/39, A61L27/22, A61L27/36, A61L27/26, A61F13/02, A61K9/70, A61P17/02
[2024/15]
CPC:
A61F13/00063 (EP,KR,MX,US); A61K38/39 (EP,KR,MX,RU,US); C07K14/78 (MX,US);
A61F13/0213 (EP,KR,MX,US); A61K9/0014 (EP,KR,MX,US); A61K9/06 (EP,MX,US);
A61K9/70 (EP,KR,MX,US); A61L27/22 (EP,KR,MX,US); A61L27/3633 (EP,KR,MX,US);
A61L27/56 (EP,KR,MX,US); A61P17/02 (EP,KR); A61P41/00 (EP,RU);
A61K38/00 (EP,MX,US); A61L2400/06 (EP,KR,US) (-)
Former IPC [2024/06]A61L27/56
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/06]
TitleGerman:REGENERIERUNG VON GESCHÄDIGTEM GEWEBE[2024/06]
English:REGENERATION OF DAMAGED TISSUE[2024/06]
French:RÉGÉNÉRATION DE TISSU ENDOMMAGÉ[2024/06]
Examination procedure31.10.2023Examination requested  [2024/06]
Parent application(s)   TooltipEP14836821.0  / EP3033099
Fees paidRenewal fee
31.10.2023Renewal fee patent year 03
31.10.2023Renewal fee patent year 04
31.10.2023Renewal fee patent year 05
31.10.2023Renewal fee patent year 06
31.10.2023Renewal fee patent year 07
31.10.2023Renewal fee patent year 08
31.10.2023Renewal fee patent year 09
31.10.2023Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO9414958  (UNIV SYDNEY [AU], et al);
 [A]WO9806830  (UNIV SYDNEY [AU], et al);
 [A]WO0156595  (ENSLEY BURT D [US]);
 [A]WO2008058323  (UNIV SYDNEY [AU], et al);
 [Y]WO2010102337  (UNIV SYDNEY [AU], et al);
 [Y]WO2013044314  (UNIV SYDNEY [AU], et al);
 [A]US2013164340  (ENSLEY BURT D [US], et al);
by applicantWO2012068619
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.